Search Results - "Fancelli, D."

Pharmacological screening identified promising combination partners in marginal zone lymphoma models with secondary resistance to BTK and PI3K inhibitors by Arribas, A., Vultaggio, S., Andronache, A., Robusto, M., Fancelli, D., Cannas, E., Spriano, F., Tarantelli, C., Rossi, D., Zucca, E., Stathis, A., Varasi, M., Mercurio, C., Bertoni, F.

Get full text

Serotoninergic 5-HT3 and 5-HT4 receptor activities of dihydrobenzofuran carboxylic acid derivatives by Fancelli, D., Caccia, C., Fornaretto, M.G., McArthur, R., Severino, D., Vaghi, F., Varasi, M.

Get full text

Potent and Selective Aurora Inhibitors Identified by the Expansion of a Novel Scaffold for Protein Kinase Inhibition by Fancelli, Daniele, Berta, Daniela, Bindi, Simona, Cameron, Alexander, Cappella, Paolo, Carpinelli, Patrizia, Catana, Cornel, Forte, Barbara, Giordano, Patrizia, Giorgini, Maria Laura, Mantegani, Sergio, Marsiglio, Aurelio, Meroni, Maurizio, Moll, Juergen, Pittalà, Valeria, Roletto, Fulvia, Severino, Dino, Soncini, Chiara, Storici, Paola, Tonani, Roberto, Varasi, Mario, Vulpetti, Anna, Vianello, Paola

“…Potent and selective Aurora kinase inhibitors were identified from the combinatorial expansion of the 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole bi-cycle, a…”
Get full text

Synthesis and pharmacological profile of FCE 28654: A water-soluble and injectable ACAT inhibitor by Chiari, A., Fancelli, D., Lovisolo, P.P., Radice, A., Savoia, L., Severino, D., Ghiselli, G.

“…The synthesis and the pharmacological evaluation of FCE 28654, a novel water-soluble ACAT inhibitor, are reported. The compound positively modifies blood and…”
Get full text

3-Amino-1,4,5,6-tetrahydropyrrolo[3,4- c]pyrazoles: A new class of CDK2 inhibitors by Pevarello, Paolo, Fancelli, Daniele, Vulpetti, Anna, Amici, Raffaella, Villa, Manuela, Pittalà, Valeria, Vianello, Paola, Cameron, Alexander, Ciomei, Marina, Mercurio, Ciro, Bischoff, James R., Roletto, Fulvia, Varasi, Mario, Brasca, Maria Gabriella

“…We recently reported about the synthesis, expansion, and biological characterization of a new bicyclic scaffold toward potent Aurora-A kinase inhibitors. Here…”
Get full text

Solid phase synthesis of 2-substituted benzofurans via the palladium-catalysed heteroannulation of acetylenes by Fancelli, Daniele, Fagnola, Maria Chiara, Severino, Dino, Bedeschi, Angelo

“…The copper/palladium-promoted heteroannulation of terminal acetylenic compounds in the presence of resin bound ortho-hydroxy aryl iodides is described. The…”
Get full text

363 POSTER In vitro and in vivo molecular characterization of PHA-739358, an inhibitor of Aurora kinases by Carpinelli, P., Ceruti, R., Degrassi, A., Fancelli, D., Gianellini, L., Marsiglio, A., Croci, V., Rocchetti, M., Texido, G., Moll, J.

Get full text

Manganese(III) acetate induced cyclization of α-arylalkyl and α-(aryloxy)alkyl β-dicarbonyl derivatives by CITTERIO, A, FANCELLI, D, FINZI, C, PESCE, L, SANTI, R

Get full text

Serotoninergic 5-HT 3 and 5-HT 4 receptor activities of dihydrobenzofuran carboxylic acid derivatives by Fancelli, D., Caccia, C., Fornaretto, M.G., McArthur, R., Severino, D., Vaghi, F., Varasi, M.

“…Structure-activity relationships in a series of dihydrobenzofuran derivatives related structurally to the 5-HT 3 antagonist and 5-HT 4 agonist ADR 932 ( 1)…”
Get full text

CORRECTION OF DYSLIPOPROTEINAEMIA OF CASEIN-FED RABBIT BY FCE 27677, A POTENT NOVEL ACAT INHIBITOR by CHIARI, AUGUSTO, LOVISOLO, PIERPAOLO, FOGLIATTO, GIANPAOLO, FANCELLI, DANIELE, GHISELLI, GIANCARLO

“…Rabbits fed a wheat starch casein diet develop hypercholesterolaemia characterized by the plasma elevation of low density lipoprotein (LDL) that is caused by…”
Get full text

FCE 27677: A novel inhibitor of acyl-CoA:Cholesterol acyltransferase with potent oral hypolipidemic activity by Chiari, Augusto, Lovisolo, Pierpaolo, Radice, Adelio, Giorgini, Laura, Fancelli, Daniele, Severino, Dino, Ghiselli, Giancarlo

“…FCE 27677 ([(−)N-[2,6-bis(1-methylethyl)phenyl]-N′-[(4R,5R)-2-(4-dimethylaminophenyl)-4,5 dimethyl-dioxolan-2-yl]methylurea) is a new systemically available…”
Get full text

Imidazolylbenzopyrane derivatives: a new class of acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors by Fancelli, D, Chiari, A, Cozzi, P, Lovisolo, P, Severino, D, Ghiselli, G

“…Inhibitors of the enzyme Acyl-CoA: Cholesterol Acyltransferase are regarded as potentially useful agents in the treatment of hypercholesterolemia and…”
Get more information